0001567619-21-022503.txt : 20211223
0001567619-21-022503.hdr.sgml : 20211223
20211223162601
ACCESSION NUMBER: 0001567619-21-022503
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211221
FILED AS OF DATE: 20211223
DATE AS OF CHANGE: 20211223
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: CRUTCHFIELD BRADFORD
CENTRAL INDEX KEY: 0001246406
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39035
FILM NUMBER: 211517465
MAIL ADDRESS:
STREET 1: 6230 STONERIDGE MALL ROAD
CITY: PLEASANTON
STATE: CA
ZIP: 94547
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: 10x Genomics, Inc.
CENTRAL INDEX KEY: 0001770787
STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826]
IRS NUMBER: 455614458
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 6230 STONERIDGE MALL ROAD
CITY: PLEASANTON
STATE: CA
ZIP: 94588
BUSINESS PHONE: (925) 401-7300
MAIL ADDRESS:
STREET 1: 6230 STONERIDGE MALL ROAD
CITY: PLEASANTON
STATE: CA
ZIP: 94588
FORMER COMPANY:
FORMER CONFORMED NAME: 10X Genomics, Inc.
DATE OF NAME CHANGE: 20190315
4
1
doc1.xml
FORM 4
X0306
4
2021-12-21
0
0001770787
10x Genomics, Inc.
TXG
0001246406
CRUTCHFIELD BRADFORD
C/O 10X GENOMICS, INC.
6230 STONERIDGE MALL ROAD
PLEASANTON
CA
94588
0
1
0
0
Chief Commercial Officer
Class A Common Stock
2021-12-21
4
M
0
4688
1.20
A
47743
D
Class A Common Stock
2021-12-21
4
M
0
49910
5.04
A
97653
D
Stock Option (right to buy)
1.2
2021-12-21
4
M
0
4688
0
D
2027-10-18
Class A Common Stock
4688
0
D
Stock Option (right to buy)
5.04
2021-12-21
4
M
0
49910
0.00
D
2028-11-02
Class A Common Stock
49910
61757
D
This option, originally for 25,000 shares, of which 25,000 shares have been exercised, vested as to 1/48th of the shares on October 1, 2017, and 1/48th of the shares subject to the option vested each month thereafter, subject to the Reporting Person continuing as a service provider through each such date.
This option, originally for 125,000 shares, of which 63,243 shares have been exercised, vested as to 1/48th of the shares on October 1, 2018, and 1/48th of the shares subject to the option vested each month thereafter, subject to the Reporting Person continuing as a service provider through each such date.
/s/ Eric S. Whitaker, as Attorney-in-Fact
2021-12-23